Howie Benjamin A, Rajput Kanishka, Chow Robert
Yale New Haven Hospital, Department of Anesthesiology, New Haven, CT, USA.
Interv Pain Med. 2022 Jun 16;1(3):100108. doi: 10.1016/j.inpm.2022.100108. eCollection 2022 Sep.
Sickle cell disease (SCD) vaso-occlusive crises are the most common reason patients with SCD present for medical care in the US. The goal of this scoping review is to outline existing literature on regional anesthesia for sickle cell vaso-occlusive crises (VOC) and identify areas for future research.
We searched the Cochrane Central Register, Ovid-Medline and EMBASE, PubMed, and additional review sources to identify studies evaluating the benefit of regional anesthetic blocks for medication refractory vaso-occlusive crises in pediatric and adult patients.
One-hundred and three articles were identified through the above search methodology. Following application of the exclusion criteria, the four pediatric case reports, one pediatric case series, and one adult case report that were found during the scoping review process were analyzed given the scarcity of available published research on nerve blocks for the treatment of SCD pain crises. Five of the 6 articles involved blocks for pain refractory to patient-controlled analgesia (PCA) despite dose escalation. One case report utilized a continuous femoral block in a patient with known morphine and new hydromorphone allergy presenting with right thigh pain. One case report recounts an epidural used for labor pain that eliminated concomitant vaso-occlusive leg pain during labor. All 6 authors achieved analgesia and a marked decrease or a total discontinuation in opioids following the block. In one case, the patient was noted to have a shorter length of stay. No studies other than those reports included were found.
There is a severe dearth of evidence evaluating the benefit of regional anesthesia in SCD pain crises. Available case reports and the included case series demonstrate that regional nerve blocks are a potential tool to consider when treating refractory vaso-occlusive pain in patients with SCD. There is urgent need for future research on evaluating regional anesthesia for patients with SCD-related vaso-occlusive crisis pain.
在美国,镰状细胞病(SCD)血管闭塞性危象是SCD患者就医的最常见原因。本范围综述的目的是概述关于镰状细胞血管闭塞性危象(VOC)区域麻醉的现有文献,并确定未来研究的领域。
我们检索了Cochrane中央对照试验注册库、Ovid-Medline、EMBASE、PubMed以及其他综述来源,以确定评估区域麻醉阻滞对儿童和成人患者药物难治性血管闭塞性危象益处的研究。
通过上述检索方法共识别出103篇文章。应用排除标准后,鉴于关于神经阻滞治疗SCD疼痛危象的已发表研究稀缺,对在范围综述过程中发现的4篇儿科病例报告、1篇儿科病例系列和1篇成人病例报告进行了分析。6篇文章中有5篇涉及尽管剂量增加但对患者自控镇痛(PCA)难治的疼痛阻滞。1例病例报告对1名已知对吗啡和新的氢吗啡酮过敏且右大腿疼痛的患者使用了连续股神经阻滞。1例病例报告讲述了在分娩时使用硬膜外麻醉消除了分娩期间伴随的血管闭塞性腿痛。所有6位作者在阻滞术后均实现了镇痛,且阿片类药物显著减少或完全停用。在1例病例中,患者住院时间缩短。除这些报告外未发现其他研究。
评估区域麻醉在SCD疼痛危象中益处的证据严重匮乏。现有的病例报告和纳入的病例系列表明,区域神经阻滞是治疗SCD患者难治性血管闭塞性疼痛时可考虑的一种潜在工具。迫切需要未来开展研究,评估区域麻醉用于SCD相关血管闭塞性危象疼痛患者的效果。